pI: 8.2604 |
Length (AA): 279 |
MW (Da): 31442 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 276 | 1ne7 (A) | 1 | 281 | 52.00 | 0 | 1 | 1.7 | -2.05 |
1 | 262 | 5hj5 (A) | 1 | 262 | 54.00 | 0 | 1 | 1.75957 | -1.87 |
1 | 269 | 1ne7 (A) | 1 | 269 | 54.00 | 0 | 1 | 1.75116 | -1.81 |
1 | 262 | 1fs5 (A) | 1 | 262 | 55.00 | 0 | 1 | 1.76357 | -1.81 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | epimastigote, metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_128189)
Species | Accession | Gene Product |
---|---|---|
Candida albicans | CaO19.9703 | C. albicans glucosamine-6-phosphate deaminase |
Candida albicans | CaO19.2156 | N terminal truncated version of C. albicans glucosamine-6-phosphate deaminase |
Caenorhabditis elegans | CELE_T03F6.3 | Protein T03F6.3 |
Dictyostelium discoideum | DDB_G0278873 | glucosamine-6-phosphate deaminase |
Dictyostelium discoideum | DDB_G0286195 | PIG-L family protein |
Drosophila melanogaster | Dmel_CG6957 | CG6957 gene product from transcript CG6957-RC |
Escherichia coli | b0678 | glucosamine-6-phosphate deaminase |
Entamoeba histolytica | EHI_174640 | glucosamine-6-phosphate isomerase, putative |
Giardia lamblia | GL50803_8245 | Glucosamine-6-phosphate deaminase |
Giardia lamblia | GL50803_10829 | Glucosamine-6-phosphate deaminase |
Homo sapiens | ENSG00000163281 | glucosamine-6-phosphate deaminase 2 |
Homo sapiens | ENSG00000113552 | glucosamine-6-phosphate deaminase 1 |
Leishmania braziliensis | LbrM.32.3550 | glucosamine-6-phosphate isomerase, putative |
Leishmania donovani | LdBPK_323460.1 | glucosamine-6-phosphate isomerase, putative |
Leishmania infantum | LinJ.32.3460 | glucosamine-6-phosphate isomerase, putative |
Leishmania major | LmjF.32.3260 | glucosamine-6-phosphate isomerase, putative |
Leishmania mexicana | LmxM.31.3260 | glucosamine-6-phosphate isomerase, putative,glucosamine-6-phosphate deaminase, putative |
Mus musculus | ENSMUSG00000029209 | glucosamine-6-phosphate deaminase 2 |
Mus musculus | ENSMUSG00000052102 | glucosamine-6-phosphate deaminase 1 |
Schistosoma japonicum | Sjp_0304390 | ko:K02564 glucosamine-6-phosphate isomerase, putative |
Schistosoma mansoni | Smp_091850 | glucosamine-6-phosphate isomerase |
Schmidtea mediterranea | mk4.001705.06 | Probable glucosamine-6-phosphate isomerase |
Trypanosoma brucei gambiense | Tbg972.11.18920 | glucosamine-6-phosphate isomerase, putative |
Trypanosoma brucei | Tb927.11.16770 | glucosamine-6-phosphate isomerase, putative |
Trypanosoma congolense | TcIL3000.11.16680 | glucosamine-6-phosphate isomerase, putative |
Trypanosoma cruzi | TcCLB.511025.50 | glucosamine-6-phosphate isomerase, putative |
Trypanosoma cruzi | TcCLB.511531.50 | glucosamine-6-phosphate isomerase, putative |
Trichomonas vaginalis | TVAG_365520 | glucosamine-6-phosphate isomerase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.8520 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.8520 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.8520 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.8520 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0678 | Escherichia coli | non-essential | goodall |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.